These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4851667)

  • 1. Effect of midbrain raphe lesion and of 6-hydroxydopamine on the antinociceptive action of buprenorphine in rats.
    Cowan A; Ghezzi D; Samanin R
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):302-5. PubMed ID: 4851667
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 6-hydroxydopamine, 5,6-dihydroxytryptamine and raphe lesions on the antinociceptive actions of morphine in rats.
    Bläsig J; Reinhold K; Herz A
    Psychopharmacologia; 1973 Jul; 31(2):111-9. PubMed ID: 4578906
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Brain levels of the potent analgesic etorphine in rats and their functional significance.
    Cerletti C; Manara L; Mennini T
    Br J Pharmacol; 1974 Nov; 52(3):440P-441P. PubMed ID: 4156490
    [No Abstract]   [Full Text] [Related]  

  • 5. A role for the amygdala in the development of the cataleptic and stereotypic actions of the narcotic agonists and antagonists in the rat.
    Costall B; Naylor RJ
    Psychopharmacologia; 1974 Feb; 35(3):203-13. PubMed ID: 4597802
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats.
    Taylor KM; Clark DW; Laverty R; Phelan EL
    Nat New Biol; 1972 Oct; 239(95):247-8. PubMed ID: 4507808
    [No Abstract]   [Full Text] [Related]  

  • 7. Infuluence of 6-hydroxydopamine on the effect of morphine on the tail-flick latency.
    Nakamura K; Kuntzman R; Maggio AC; Augulis V; Conney AH
    Psychopharmacologia; 1973 Jul; 31(2):177-89. PubMed ID: 4722208
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of 6-hydroxydopamine on the antinociceptive action of morphine.
    Slater P; Blundell C
    Eur J Pharmacol; 1978 Apr; 48(3):237-47. PubMed ID: 639852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased anticonvulsant activity of carbamazepine in 6-hydroxydopamine-treated rats.
    Quattrone A; Samanin R
    Eur J Pharmacol; 1977 Feb; 41(3):336-6. PubMed ID: 837975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 13. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine.
    Breese GR; Prange AJ; Howard JL; Lipton MA; McKinney WT; Bowman RE; Bushnell P
    Nat New Biol; 1972 Dec; 240(104):286-7. PubMed ID: 4633263
    [No Abstract]   [Full Text] [Related]  

  • 14. The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.
    Vetulani J; Reichenberg K; Wiszniowska G
    Psychopharmacologia; 1974; 38(2):173-80. PubMed ID: 4460073
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

  • 16. The increased efficacy of narcotic antagonists induced by various narcotic analgesics.
    Tulunay FC; Takemori AE
    J Pharmacol Exp Ther; 1974 Sep; 190(3):395-400. PubMed ID: 4416308
    [No Abstract]   [Full Text] [Related]  

  • 17. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonists in the 5-phenyl-benzomorphan series.
    Clarke FH; Hill RT; Saelens JK; Yokoyama N
    Adv Biochem Psychopharmacol; 1973; 8(0):81-9. PubMed ID: 4211809
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine.
    Samanin R; Ghezzi D; Valzelli L; Garattini S
    Eur J Pharmacol; 1972 Sep; 19(3):318-22. PubMed ID: 4640855
    [No Abstract]   [Full Text] [Related]  

  • 20. Consummatory behaviors of hypothalamic hyperphagic rats after central injection of 6-hydroxydopamine.
    Coscina DV; Rosenblum-Blinick C; Godse DD; Stancer HC
    Pharmacol Biochem Behav; 1973; 1(6):629-42. PubMed ID: 4785805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.